News related to Taxol (Paclitaxel) and/or conditions it is approved for
Taxol Boosts Odds of Chronic Pain
Source: MedicineNet Peripheral Neuropathy Specialty [2009.12.03]
Title: Taxol Boosts Odds of Chronic Pain
Category: Health News
Created: 12/3/2009 10:07:00 AM
Last Editorial Review: 12/3/2009 10:07:15 AM
Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapy
Source: MRSA / Drug Resistance News From Medical News Today [2010.01.28]
Taxanes, a group of cancer drugs that includes paclitaxel (Taxol®) and docetaxel (Taxotere®), have become front-line therapy for a variety of metastatic cancers. But as with many chemotherapy agents, resistance can develop, a frequent problem in breast, ovarian, prostate and other cancers...
PERSEUS Trial Results Demonstrate Positive Safety And Efficacy Outcomes For Boston Scientific's Novel Platinum Chromium TAXUS® Element Stent
Source: Cardiovascular / Cardiology News From Medical News Today [2010.03.16]
Boston Scientific Corporation (NYSE: BSX) announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS® Element™ Paclitaxel-Eluting Stent System compared to the TAXUS® Express2™ Paclitaxel-Eluting Stent System...
Study Shows Superior Efficacy For TAXUS(R) Express(R) Stents At One Year Compared To Bare-Metal Stents In Diabetic Patients Experiencing Heart Attack
Source: Diabetes News From Medical News Today [2010.03.16]
Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2™ Paclitaxel-Eluting Stent System or the Express® bare-metal stent...
|
